Structural analysis of the promoters of several endothelial genes induced at sites of inflammatory or immune responses reveals binding sites for the transcription factor nuclear factor KB (NF-KB). Endothelial cells express transcripts encoding the pS0/p105 and p65 components of NF-IcB and the tel-related proto-oncogene c-re/; steady state levels of these transcripts are transiently increased by tumor necrosis factor ce (TNF-ce). Western blotting revealed that stimulation of endothelial calls with TNF-ce resulted in nuclear accumulation of the p50 and p65 components of NF-KB. Ultraviolet crosslinking and immunoprecipitation demonstrated binding of the p50 and p65 components of NF-KB to the E-selectin xB site. Endothelial cells express an inhibitor of NF-gB activation, IgB-ce (MAD-3). Protein levels of this inhibitor fall rapidly after TNF-cx stimulation. In parallel, p50 and p65 accumulate in the nucleus and RNA transcript levels for IgB-o~ are dramatically upreguhted. Recombinant p65 stimulates expression of E-sdectin promoter-reporter constructs. IKB-ce inhibits p65 or TNF-ce-stimulated E-sdectin promoter-reporter gene expression in transfected endothelial cells. The NF-gB and IKB-ce system may be an inducible regulatory mechanism in endothelial activation.
A
sites of inflammation and cell-mediated immune responses, endothelial cells develop a characteristic morphology and synthesize new proteins not present in resting vascular beds. These alterations in endothelial cell function are part of a process termed endothelial activation (for a review see reference 1). Many of these morphologic and functional changes can be induced in cultured endothelial cells by purified immune mediators, such as monokines, lympbokines, and bacterial LPS. Based on these in vitro studies, it has been proposed that resident tissue cells and infiltrating lenkocytes release cytokines during inflammatory and immune responses that cause endothelial cells to become activated. The activated endothelial cells express new surface proteins and soluble mediators that subsequently recruit additional circulating cells to the peripheral tissues. Many inducible genes involved in endothelial activation, including vascular cell adhesion molecule 1 (2, 3), E-selectin (4, 5) , tissue factor (6), IL-1 (7), IL-6 (8), G-CSF (9), IL-8 (10) and c-rayc (11) , contain elements in their promoter regions that could be recognized by the nuclear factor xB (NF-gB)I/Rel family of transcrip-M. A. Read and M. Z. Whitley contributed equally to this paper.
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DTT, dithiothreitol; EMSA, electrophoretic mobility shift assay; FBS, fetal bovine serum; NF-~B, nuclear factor ~B; VCAM-1, vascular cell adhesion molecule 1. tion factors. With some of these genes, deletion analysis has demonstrated that the NF-KB sites are functional elements in cytokine or LPS-induced endothelial expression (2) (3) (4) .
NF-xB is a transcription factor associated with rapidresponse activation mechanisms (for reviews see references [12] [13] [14] [15] . The NF-KB protein subunits, pS0 (NFKB1, derived from its p105 precursor) and p65 (Rd A), belong to the Rel fam~y of genes that also includes p52 (NFKB2 and its pl00 precursor, also called lyt-10), the v-,el oncogene, c-tel protooncogene products, and the Drosophila morphogen dorsal. In resting cells, NF-xB binding proteins are in an inactive cytosolic form and are complexed to members of a family of inhibitory proteins referred to as IKB. Several IxB proteins have been cloned or purified including bcB-c~ (MAD3), IKB-~, p105, IKB-3, and bcl-3 (for reviews see references 12, 15) . All IxB forms identified to date contain multiple ankyrin repeats, which are involved in interactions with NF-KB. NF-gB can be activated by a number of diverse agents, such as the cytokines IL-I~ and TNF-c~, LPS, oxidative stress and viral products. These agents initiate the nuclear translocation and subsequent DNA binding of NF-KB, possibly by posttranslational modifications that result in loss of inhibition by IKB proteins (12) (13) (14) (15) . One of these inhibitors, IgB-c~, binds the p65 subunit preferentially and is released from p65 after phosphorylation in response to mediators which activate NF-~B (16) (17) (18) (19) . The existence of multiple Rel family members and I~B subunits emphasizes the need to examine the structure and regulation of the transcription factor in specific cell types and biologic contexts.
A growing body of evidence suggests that the NF-KB/IgB system might play a regulatory role in endothelial activation (for a review see reference 20). NF-gB can be activated by a number of stimuli relevant to endothelial activation, and functional NF-gB sites are found in many genes whose expression is increased at sites of inflammatory responses. In support of this proposal, it has been reported that cytokine or LPS activation induces NF-gB-like DNA-binding activity in endothelial cells (e.g., [2] [3] [4] [5] 21) . However, these studies do not establish the repertoire of Rel family members expressed by endothelial cells, the identity of the family members involved in gB complex formation, or the role of IgB in regulating NF-gB activation in endothelial ceils. Here we define the dynamic pattern of expression of the Rel proteins expressed by endothelial ceUs in response to TNF-o~ stimulation and show that specific members of the family are functionally important in the cytokine-induced expression of a leukocyte adhesion molecule, E-select-in. Furthermore, we provide evidence for a rapid loss of IgB-ol in endothelial cells stimulated with the TNF-c~. The time course of this loss correlates with the appearance of nuclear p50 and p65, as well as NF-gB binding activity. IgB-ol is rapidly resynthesized after the loss, suggesting an autoregulatory mechanism for NF-gB regulation in endothelium.
Materials and Methods
Cell Cultures. Human endothelial cells obtained from collagenase-digested umbilical veins (22) were cultured in M199 with 20% fetal bovine serum (FBS), 100 #g/m1 porcine intestinal heparin, 50 #g/ml endothelial mitogen, 50 U/ml penicillin and 50 #g/ml streptomycin, and 25 mM Hepes in gehtin-coated plates. Confluent monolayers (3-5 x 106 cells, passages 2-4) were exposed to recombinant human TNF-c~ (Genentech, San Francisco, CA) at a final concentration of 100 or 200 U/ml in complete media. Bovine aortic endothelial cells (BAEC) were isohted and maintained in culture using modifications of previously described procedures (2) .
Northern Analysis. Total RNA from 107 cells was isolated by the guanidine isothiocyanate method (23) . RNA was separated by electrophoresis on a 1% agarose formaldehyde gel, transferred to Hybond-N membrane (Amersham Corp., Arlington Heights, IL), and immobilized by UV irradiation with a UV StratalLnker 2400 (Stratagene, La Jolla, CA). Blots were prehybridized for 6 h and hybridized overnight (24) at 42~ with 3Zp-labeled probes (Megaprime kit; Amersham Corp.). eDNA clones for p65, p50/p105, c-Rel, and IKB-c~ were generously provided by Michael Lenardo (National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD), Gary Nabel (Howard Hughes Medical Institute, University of Michigan Medical Center, Ann Arbor, MI), and Stephen Haskill (University of North Carolina, Chapd Hill, NC).
CellExtmcts. After experimental treatment of endothelial cells, nuclear and cytosolic extracts were prepared as described by Moliter et al. (25) with the following modifications. Cell monohyers (3-5 x 10 e cells) were harvested by scraping, washed in cold PBS, and incubated in 100 #1 of buffer A (10 mM Hepes, pH 8.0, 1.5 mM MgClz, 10 mM KC1, 0.5 mM dithiothreitol (DTT), 200 mM sucrose, 0.5 mM PMSF, 1 #g/m1 leupeptin, 1 #g/ml aprotinin, and 0.5% NP-40) for 10 min at 4~ The crude nudei released by lysis were collected by microcentrifugation and the cytosolic extracts frozen on dry ice. The nuclear pellet was rinsed once in buffer A and resuspended in 100/zl of buffer B (20 mM Hepes, pH 8.0, 20% glycerol, 0.1 M KC1, 0.2 mM EDTA, 0.5 mM PMSF, 0.5 mM DTT, and 1 #g/ml each lenpeptin and aprotinin). Nuclei were sonicated for 10 s at 15% power output (Virsonic Cell Disruptor; Virtis, Gardner, NY) and clarified by microcentrifugation for 30 s. The resulting supernatants contained 1-2 mg/ml protein by Bradford assay (26) with BSA as the standard. Nuclear extracts were frozen on dry ice and stored at -80~
Electrophoretic Mobility Shift Assay (EMSA). A double-stranded oligonucleotide containing the E-sdectin NF-xB site (5'-AGCTTA-GAGGGGATTTCCGAGAGGA-Y) was end-labeled with cr ATP (50 #Ci at 3,000 Ci/mmol, New England Nuclear, Boston, MA) and the Klenow fragment ofEscherichia coli DNA polymerase I. Binding reactions in 20 #1 contained 15 #g nuclear extract protein, binding buffer (10 mM Tris, pH 7.5, 20 mM NaC1, 1 mM DTT, 1 mM EDTA, 5% glycerol, 1 #g poly dI-dC, 1 #g singlestranded salmon testes DNA), and 100,000 cpm 321Mabeled DNA. Reactions were incubated at room temperature for 20 rain and analyzed by electrophoresis on a 4% nondenaturing polyacrylamide gel at 180 V for 2 h using the high ionic strength conditions described by Ausubel et al. (24) . After electrophoresis, gels were dried and DNA-protein complexes localized by autoradiugraphy for 18 h. Competition studies were performed by adding unlabeled doublestranded oligonucleotides to the binding reaction before the addition of labeled oligonucleotide. Competitor oligonucleotides included the wild-type NF-~B sequence (specified above), and an NF-KB 5' mutant (5'-AGCTTAGATTTTATTTCCGAGAGGA-3'). Competition reactions were incubated for 10 min before addition of labeled oligonucleotide. For supershift analysis, nuclear extracts from TNF-cc-treated endothelial cells were incubated with 2 #1 of antisera or nonimmune rabbit serum for 15 min at room temperature before addition of binding buffer containing labeled oligonucleotide. Samples were subjected to electrophoresis as described above.
Antibodies to NF-r,B and lr, B Proteins. Peptide-specific rabbit antisera to p65, pS0, and c-Rel were generously provided by Warner Greene (Gladstone Institute of Virology and Immunology, University of Califoruia, San Francisco, CA) (27) . Anti-IKB-c~ was generously provided by Stephen Haskill (16, 28) .
UV-CrosslinkingandlmmunoFrecipitation. Photoreactive labeled DNA probes were prepared by annealing coding strand temphte (29) . DNA binding reactions performed in 20 #1 as described above but using the BrdU substituted probe, were UV irradiated for 15 min using a transilhminator (Fotodyae Inc., New Berlin, WI). For immunoprecipitation, radiolabeled adducts were diluted in 180 #1 ELB buffer (50 mM Hepes-CI, pH 7.9, 250 mM NaC1, 0.1% NP-40, 5.0 mM ED~, 0.5 mM DTT, and supplemented with 200 #g/m1 BSA, as well as 1 mM PMSF and I #g/ml each of leupeptin and aprotinin) and incubated with 1 #1 antisera (1 h on ice) followed by 20 #1 protein A-Sepharose (1 h on ice). Immune complexes were washed three times with ELB buffer and analyzed on 8% SDS-polyacrylamide gels.
Western Blot Analysis. Nuclear and cytosolic extracts from cytokine-treated human umbilical vein endothelial cells were electrophoresed on 8% SDS polyacrylamide gels and transferred to nitrocellulose in 25 mM Tris, 192 mM glycine, 5% methanol at 100 V for 1.5 h at 4~ Western blots were analyzed for p50, p65, c-gel, and I~B-c~ using antiserum at a 1:10,000, 1:10,000, 1:10,000, and 1:5000 dilution, respectively. Immunoreactive proteins were detected according to the enhanced chemiluminescence protocol (Amersham) using 1:10,000 horseradish peroxidase-linked donkey anti-rabbit secondary antiserum. Blots were exposed to film for 1-15 rain.
E-Selectin Promoter Growth Hormone Receptor Constructs and Expression
Constructs. An E-selectin promoter fragment (30) was generated by PCP, amplification and cloned into pOGH (Nichols Institute Diagnostics, San Juan Capistrano, CA) to obtain an E-selectin-GH hybrid reporter construct. The 613-bp PCK fragment (-578 to +35) was gel purified, treated with Klenow to assure blunt ends, phosphorylated by polynucleotide kinase and bluntend ligated into XbaI-cut and end-filled pOGH. The internal deletion construct, pGH(-578)AKB was made using two rounds of PCR amplification. Briefly, subfragments were generated corresponding to -578 to -100 and -75 to +35 which included the SalI sites at the -100 and -75 ends. The subfragments were digested with Sall, Ligated overnight, and used as the template for a second round of amplification with forward -578 and reverse + 35 primers. The product of the second amplification was cloned into Xba-ldigested pOGH as above. The DNA sequences of the promoterreporter constructs were confirmed by dideoxynudeotide sequencing. To generate expression vectors, Nod fragments of p65 and p105/p50 were cloned into the NotI site ofpcDNA (Invitrogen, San Diego, CA). An EcoRI restriction fragment containing the complete open reading frame of bcB-c~ was cloned into the EcolLI site of pcDNA.
DNA Sequencing. Nucleotide sequence was determined by the dideoxynucleotide chain termination method with modified T-7 polymerase (United States Biochemical, Cleveland, OH) and c~-[3sS]dATP (New England Nuclear). Oligonucleotide primers were synthesized on a oligonucleotide synthesizer (model 381A; Applied Biosystems, Foster City, CA) and used without purifi~:ation.
Transfection of Vascular Cells and Transient Expression of Chimeric
Constructs. Subconfluent human umbilical vein endothelial cultures (106 ceUs/100-mm culture dish) and bovine aortic endothelial cells were transfected by a modified calcium phosphate precipitation technique (23) . 1 h before transfection, M199 media was replaced with DMEM supplemented with 10% FBS, penicillinstreptomycin, and L-glutamine. Cells were transfected with 20 #g of reporter phsmid and 0.5-1.0 #g p50 or p65 expression phsmids. All plates were balanced for total amount of DNA with an inert pBS vector. Relative transfection efficiency was determined by cotransfection with 5 #g pCATcontrol (Promega, Madison, WI). Bovine aortic endothelial cells were transfected with 10 #g of Is~B-ot expression phsmid, 10 #g reporter plasmid, and 2.5 #g of PDGF B chain promoter-CAT vector (31) . After tranffection, cultures were washed twice with HBSS. Complete endothelial media and TNF-c~ were added 2 h hter. 48 h after washing, samples of the medium were collected and assayed for growth hormone by using a comme~.afiy available P, IA kit (Nichols Institute Diagnostics, Geneva, Switzerland). Cells were harvested by trypsin dissociation, centrifuged (650 g for 5 min), washed once in PBS, and resuspended in 0.10 rnl of 0.25 M Tris-HC1 (pH 7.8) with 10 ~g/ml aprotinin (Sigma Chemical Co.). Calls were lysed by sonication and one fieezethaw cycle. Supernatants containing the cell extracts were obtained after centrifugation for 10 min at 14,000g and stored at -20"C. Transfection of the E-selectin promoter-GH reporter constructs was performed in duplicate for each experiment and the experiments were repeated at least three times using at least two independent plasmid preparations. Bach experiment included a negative control, the promoterless plasmid, pOGH, and a positive control, pTKGH.
Conversion of radiohbded acetyl-coenzyme A to acetylated chloramphenicol was assayed by the two phase fluor diffusion technique (23) . For each sample, 30-50 #1 of cell extract was incubated at 65~ for 15 min to inactivate endogenous transacetyhses. The assay was performed in a reaction mixture of 1.25 mM chloramphenicol (Sigma Chemical Co.), 125 raM Tris-HC1, pH 7.8, and 0.1 #Ci of [3H]-acetyl coenzyme A (New England Nuclear) in a reaction volume of 0.2 ml. The reaction mixture was overlaid with 5 ml of water immiscible scintillation fluid (Econofluor; Dupont, Wilmington, DE) and incubated at 37~ for 2 h. The activity of the [3H]-acetylated chloramphenicol was measured on a geckbeta scintillation counter (LICK Piscataway, NJ). Fig. 1 shows Northern blot analysis ofP, NA from endothelial cells activated by TNF-c~. Transcript levels from two NF-~cB-dependent leukocyte adhesion molecules, E-selectin and VCAM-1, are shown for comparison (Fig. 1  A) . p65 mRNA (2.6 kb [32] ) was present constitutively and increased slightly after cytokine activation, p105/pS0 tran- script (3.8 kb [33, 34] ) was constitutively present at low levels, increased at 3 h, and gradually returned to basal levels. The two transcripts for c-Rd, >10.5 and 3.5 kb (35) were present in control cultured endothelial cells (Fig. 1 B) . Levels of both transcripts increased transiently in parallel after TNF-c~ stimulation and then decreased to bdow control levels kB-oe transcript (28) levels increased dramatically in response to TNF-(a and remained elevated (Fig. 1 C) . Thus, TNF-c~ activation of endothelial ceils caused a significant but transient increase in p65, p105/p50, and c-Rel, as well as a rapid increase in the transcript levels of a potential inhibitor of NF-r,B, IKB-ol.
Results

Cytokine-induced Expression of NF-/cB ~anscripts in Cultured Endothelial Cellz
NF-rdt Binding to the E-selectin gB Site in Cuhured Endothelial Cells. The preceding observations establish that endothelial cells express transcripts for Re1 family members and that levels of these transcripts can be modulated by TNF-ol. Of the many induced genes at sites of endothelial activation which have KB sites, we have elected to further characterize the KB site from the E-sdectin gene (4, 30) as an example of an NFgB-dependent gene in endothelium. Nuclear extracts were prepared and assayed for NF-KB binding activity using the EMSA. TNF-c~ specifically induced two NF-tcB--DNA binding complexes in endothelial cells (Fig. 2 A, lanes 1 and 2) . Competition of complexes A and B by unlabeled wild-type oligonudeotide, but not by a mutant oligonucleotide, verified the specifically of binding to DNA (Fig. 2 A, lanes 3-6) . A third complex (c) was constitutively expressed (Fig. 2 A, lane I) and was not competed by the highest concentration of unlabeled wild-type oligonucleotide, or by mutant NFgB oligonudeotides (Fig. 2 A, lanes 3-6) . Similar complexes in endothelial cells have been seen in response to LPS and with other sB sites (e.g., 2, 3, 21).
To determine which proteins were present in the E-selectin KB-DNA complexes induced by TNF-c~, human umbilical vein endothelial cell nudear extracts were incubated with 2 #1 of normal rabbit serum or antisera to p50, p65, and c-tel before the EMSA. As shown in Fig. 2 B, normal rabbit serum did not affect complex formation (lane 2). Anti-pS0 eliminated and/or caused a supershift in both induced complexes A and B (Fig. 2 B, lane 3) . Anti-p65 caused a supershift of complex A, but did not affect formation of complex B (Fig.  2 B, lane 4) . Anti-c-Rel did not alter formation of either complex A or B (Fig. 2 B, lane 5) , although this antibody did recognize c-Rel expressed by a human monocytic cell line (THP-1) (18) and in extracts of Jurkat cells (data not shown) in a similar rB supershift analysis. None of the antisera affected formation of the nonspecific complex (c). Thus, the induced complexes contain p50 and p65 (complex a) and p50 (complex a) NF-rB DNA-binding proteins, but not c-Rel.
Biochemical characterization of E-selectin KB binding proteins present in nuclear extracts of control and TNF-ot-treated human umbilical vein endothelial cells was accomplished by UV crosslinking analysis. A photoreactive form of the E-selectin KB probe was incubated with nuclear extracts from uninduced and TNF-c~-treated endothelial cells. After UV irradiation, the resulting protein-DNA adducts were directly resolved by SDS-PAGE (Fig. 3 A) or immunopredpitated with antisera to p50, p65, and c-Rel, and then resolved by SDS-PAGE (Fig. 3 B) . TNF-c~ induced the formation of three major DNA protein adducts which migrated at 75 kD and as a 50-55-kD doublet (Fig. 3 A, lane 4) . These adducts were specifically competed with unlabeled wild-type oligonucleotide but not mutant oligonudeotide (Fig. 3 A, lanes 5 and  6) . The molecular weights of these adducts are consistent with previously described p65 and p50 UV crosslinked adducts (25) . Low levels of these adducts were observed in nuclear extracts from uninduced cells (Fig. 3 A, lanes 1-3) . Immunoprecipitation analysis was used to identify these adducts. From TNF-c~-induced nuclear extracts, anti-p65 identified a 75-kD adduct, corresponding to the predicted mobility of p65 covalently bound to the oligonucleotide (Fig. 3 A, lane  7) and the 50-55-kD adducts (lane 7). Anti-p50 coimmunoprecipitated a 75-kD adduct (p65) and two 50-55-kD adducts (Fig. 3 B, lane 6) . Denaturation by heating in SDS before immunoprecipitation confirmed that anti-p50 recognized only the 50-55-kD adducts, and that anti-p65 recognized only the 75-kD adduct (data not shown). Anti-c-Rel failed to immunoprecipitate the expected 85-kD adduct, consistent with the lack of immunoreactivity by gel shift analysis. From uninduced nuclear extracts, p50 immunoprecipitated small amounts of 50-55-kD adducts (Fig. 3 B, lane 2) .
Cytoleine-induced Changes in IgB-~ and NF-r,B Protein Levels in Cultured Endothelial Cells.
To assess the dynamics of Ir.B-ee protein expression occurring during endothelial activation, human umbilical vein endothdial cells were treated with TNF-c~, and subcellnlar fractions were subjected to immunoblotting (Fig. 4 A) and gel shift analysis (Fig. 4 B) . Cyto- solic extracts from cells exposed to TNF-ot for the times shown in Fig. 4 A (lanes 2-9) were analyzed by Western blotting using antisera raised to an IKB-o~ peptide (16, 19) . A 37-kD protein was detected in cytoplasmic extracts from unstimulated cells (Fig. 4 A, lane 2) which comigrated with IxB-ot present in extracts from COS cells transfected with an exogenous I~B-ot cDNA expression vector (Fig. 4 A, lane 1) . In endothelial cells treated with TNF-ot, cytoplasmic I~B-ot completely disappeared within 15 mitt of stimulation. Ir, B-cz gradually reappeared in the cytoplasm (Fig. 4 A) . IKB-ot did not accumulate in endothelial nudear extracts (data not shown). The time course of the depletion of IKB-ot after stimulation correlates with the nuclear appearance of NF-gB (Fig. 4 B) . After 15 rain of TNF-ot exposure, NF-KB binding activity is present in endothelial nuclear extracts and IKB-ot levels have fallen dramatically (Fig. 4 B, lane 2) . Although steady state levels of I~B-ot mRNA were dramatically upregulated by TNF-c~ (Fig. 1 C) , cytosolic IKB-cz remained below baseline levels, perhaps indicating continuous degradation in response to cytokine. Nuclear NF-KB binding remains elevated (Fig.   4 B, lanes 6-8) for 24 h, consistent with the failure of cytosolic IKB-cx to return to baseline levels (Fig. 4 A, lanes 7-9) . At this time, there is no transcription from the E-selectin gene (4, and Fig. 1 A) . Therefore, NF-xB cannot be entirely responsible for the temporally regulated pattern of cytoldneinduced E-selectin gene expression in endothelial cells.
Immunoblotting analysis of the same nuclear and cytosolic extracts revealed that the loss of IxB-ot in the cytoplasm correlated with the translocation of p50 and p65 from the cytoplasm into the nucleus. Cultured endothelial cells have a substantial pool of both pS0 and p65 in a cytoplasmic reserve (Fig. 5) . Consistent with the UV-crosslinking analysis (Fig. 3 B, lane 2) , p50 was present in small amounts in uninduced nuclear extracts, whereas p65 and c-Rel were not detected (Fig. 5, lane 9) . After 15 rain of TNF-c~ stimulation, both NF-gB components pS0 and p65 were markedly increased in the nucleus (Fig. 5, lane 10) , consistent with the kinetics of induction of KB binding (Fig. 4 B) , as well as the supershift (Fig. 2 B) and UV crosslinking analyses (Fig. 3, A and  B) . Cytoplasmic pools of p50 and p65 were not depleted in parallel with the nuclear translocation of these NF-KB components. After activation, nuclear p50/p65 levels remained high despite the appearance of newly synthesized IgB-ot (Fig.  5 A) . The mechanism by which NF-~B persists in the nucleus with continued cytokine stimulation is unclear, c-Rel was seen in endothelial cells which comigrated with the c-Rel present in cytoplasmic extracts from Jurkat cells (Fig. 5, lane  J) . Relative to the amount of c-Rel found in comparable numbers of Jurkat cells, the level of c-Rel in cytoplasmic extracts of cultured human endothelial cells was low. In striking contrast to the results with pS0 and p65, c-Rel was not detected in the nucleus with cytokine stimulation. Thus, in endothelial cells, various Rel related proteins can coexist and respond independently to environmental signals.
A
Regulation of E-selectin Gene Expression by Recombinant NF-r,B
Components. These findings establish that p50 and p65 rapidly translocate into the nucleus of TNF-o~-treated endothelial cells and are capable of binding to the E-selectin gB site. These observations, however, do not establish the functional significance of these NF-KB components in the transcriptional regulation of the E-sdectin gene. Previous deletion analysis in endothelial cells revealed that the JoB site in the E-sdectin core promoter was necessary (but not sufl~dent) for the cytokine responsiveness of the gene (4). The NF-~B motif in the E-sdectin promoter (GGGGATTTCC) is completely conserved in both the human (30) and the rabbit (36) promoters and is in agreement with a consensus sequence (GGRNTTTCC) for p65 binding (37) . Little variation is tolerated in the 3' half-site of p65 binding sites (37) , and interestingly, in the mouse E-selectin gene, only the 3' half site of the functional NF-xB promoter dement is conserved (38) . The structure of the E-selectin NF-KB site suggests that the p65 component of NF-gB could play an important role in the induced expression of the E-selectin gene. The potential function of the KB site in the E-selectin gene was analyzed by cotransfection experiments with an E-selectin promoter reporter construct and various NF-KB expression constructs, p65, or mixtures of p50 and p65, stimulated expression of the chimeric reporter gene. The responsiveness of the E-sdectin promoter to stimulation was dependent upon the KB regulatory dement. Responses were similar in either human umbilical vein endothelial cells (Fig. 6 A) , or BAEC (data not shown). Similar results were obtained with p65 expression constructs and a VCAM-1 promoter-reporter construct (39) . These results are consistent with the finding of r.B binding proteins observed in nuclear extracts from cytokinestimulated endothelial cells and suggest that p65, either alone or in combination with p50, can induce expression of at least two NF-KB-dependent genes in endothelial cells.
Ir, B-~ Inhibits F65 and TNF~-stimulated E-Selectin-Reporter Gene. To determine whether induced E-selectin gene expression by NF-KB could be regulated by IgB-c~, expression vectors for different NF-gB subunits were cotransfected with an expression vector for IgS-c~ and an E-selectin-reporter gene_ With an E-selectin-GH reporter, transfection of I~B-c~ almost completely abolished marker gene expression stimulated by p65 in bovine endothelial cells (Fig. 6 B, lanes 7 and 8) , as well as in human umbilical vein endothelial cells and COS cells (data not shown). These findings demonstrate that the transcriptional activation of the E-sdectin gene induced by NF-KB can be regulated by IsB-c~. Similar results were obtained with p65, IxB-c~, and a VCAM-1 promoter-reporter construct (39) , raising the possibility that IgB-c~ may regulate expression of multiple NF-KB-dependent genes in endothdial cells.
These findings are consistent with the inhibition of p65-mediated transcription by transfected IKB-c~ reported earlier with other cell types and different reporter genes (e.g., 16, 17) . To extend these observations, we determined whether IxB-a could block E-sdectin reporter gene expression induced by TNF-ol in endothelial cells (Pig. 6 B). Endothelial cells were transfected with an E-sdectin-GH reporter, the IsB-cz expression vector, and then challenged with human TNF-cz. Transfection of the I~B-a expression vector blocked the TNF-a-induced expression of the E-selectin reporter gene (Fig. 6 B, lanes 5 and 6) . Suppression of the E-sdectin-GH expression by IKB-a was dose dependent (data not shown). In contrast, a constitutively expressed reporter gene (thymidine kinase-growth hormone, pTKGH), was not affected by expression of IsB-a (Fig. 6 B, lanes 9-11) , suggesting that the suppressive effect was specific for genes that are dependent upon NF-xB. These studies demonstrate that IgB-a can suppress TNF-a-induced expression of an E-selectin reporter gene in cultured endothelial cells.
Discussion
These studies demonstrate that human endothelial cells express multiple members of the Rel family transcription factors, and that stimulation by TNF-c~ results in translocation of p50 and p65 to the nucleus. The functional significance of two of these factors in endothelial gene regulation was demonstrated by transient transfection analysis, where cotransfection of p65 or p65/p50 resulted in increased levets of expression of an E-selectin-reporter construct. Endothelial cells also express an inhibitor of NF,-xB activation, Ir~B-c~, and can dramaticaUy modulate the level of this inhibitor in paralld with the activation process. IxB-c~ is functionally relevant in cytokine-induced expression of E-sdectin, in that overexpression of this protein in endothelial cells blocks TNF-c~ and p65-mediated expression of an E-sdectin promoter-reporter gene. These data suggest that NF-KB and IKB-c~ are involved in cytokine~mediated signaling and may play an important role in regnhtion of gene expression during endothelial activation.
Regnlation of the NF-xB/IxB-c~ system in endothelial cells may be a tightly controlled process that ensures that the endothelium can make appropriate responses to environmental stimuli. The presence of cytoplasmic pools of p50 and p65 in endothelial cells suggests that the cells are primed for activation. If endothdial cells arc similar to other cell types, the NF-KB heterodimers are maintained in the endothelial cytoplasm by IxB-c~ (for reviews see references [12] [13] [14] [15] ). Here we demonstrate that activation-induced IgB-c~ degradation in endothelial cells is coupled to NF-gB nuclear translocation. Specific signals, such as cytokines or LPS, release p50/p65 from the Ir, B-c~, resulting in rapid translocation of transcriptionally active heterodirners to the endothelial nucleus. The exact signal transduction pathways for activating NP-~B in endothelial calls are not understood, although TNF-c~-induced cell adhesion to human endothdial ceils is mediated through the 55-kD TNF-c~ receptor (40) . In other cell types, TNF-c~ has been shown to activate NF-xB through generation of ceramide, which is released fi:om sphingomyelin by enzymatic hydrolysis (41) . Other Rd-related factors in endothdial cells, specifically, c-Rel, may be activated by distinct, as yet undefined stimuli.
The full complement of physiologically relevant target genes for NF-KB in endothelial cells is not dear. The nature of the responsive target genes probably depends upon the activation of specific Rel-related protein complexes and the structure of the r,B sites (37). Here we demonstrate that pS0/p65 act on the E-sdectin promoter, and in parallel studies suggest that the VCAM-1 gB sites are also a target of NF-KB activation (39) . Additionally, we show here that the genes that code for p65, p105, and IxB-c~ are highly inducible in endothelial cells in response to the stimuli that activate NFgB. These results are consistent with recent observations that the promoter of the IKB-c~ gene contains xB binding sites (42) and that p65 stimulates IKB-ce gene expression (42) (43) (44) (45) . Thus p65 and IgB~ have been directly linked in an auto~mla-tory loop. Additionally, p65 stabilizes IgB-c~ protein (43, 45) , which may help to maintain cytoplasmic levels of the inhibitor. The significance of the autoregulatory loop for NF-JcB and hoB-or is that it allows a continuous maintenance of the cytoplasmic reservoirs of NK-~B complexes for stimulation in an acute response, and also prepares the endothdial cell to return NF-KB to its uninduced condition.
The NF-~B and IKB-ot mechanism insures that the induction of NF-KB is transient and that the activated endothelial cell returns to a quiescent state within a relatively short period. The rapid cytokine-induced activation of NF-gB in endothelial cells is probably similar to that seen in other cell types; however, the recovery kinetics of the NF-gB/IgB-ot response in endotbelium may be different. The data presented here suggest that NF-~B remains activated and I~cB-c~ levels remain below basal levels for longer periods of time than seen in cells programmed for rapid responses, such as macrophages. It is possible that cytokines released by activated endothdial cells result in an autocrine activation of NF-r,B and continued degradation of IrB-o~. Such prolonged endothelial activation may play a role in recruiting circulating cells to sites of ongoing inflammatory or immune processes.
The regulation of NF-JcB activation may be important in the initial onset of multiple forms of vascular pathobiology.
Situated between the circulating blood elements and the surrounding tissues, vascular endothelium is in a privileged anatomic setting. Endothdial cells at sites of inflammatory responses are exposed to activating cytokines and various forms of reactive oxygen SlX'des. Many of these agents may have in common the ability to generate oxidant stress and activate NF-KB (46) . Since multiple genes relevant to the pathobiology of endothelial activation have potentially functional NF-~cB sites, activation of the pldotropic mediator NF-gB in endothelial cells could coordinate the expression of numerous endothelial products which are important in endothelial activation, including some cell surface adhesion proreins, cytokines, growth factors, and components of the coagulation system. These endothelial cell products may act cooperatively to facilitate inflammatory or immune responses. Increased expression of inhibitors of NF-gB activation might decrease NF-KB activation and diminish expression of NFgB-dependent genes. This regulatory mechanism insures that the induction of NF-tcB is transient and that the activated endothelial cell returns to a quiescent state. This dynamic balance might be offset during the initial onset of vascular pathology, such as in the initiation of the atherosclerotic lesion (47) .
